Emcure Pharma receives USFDA EIR for Sanand facility; regulator classifies it as ‘VAI’; here’s what it means

Emcure Pharma received a USFDA EIR for its Sanand facility, classified as Voluntary Action Indicated (VAI). The company’s Q1 net profit rose 42%.

Leave a Reply

Your email address will not be published. Required fields are marked *